Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic algorithm for chronic obstructive pulmonary disease.

K R Chapman1

  • 1Division of Respiratory Medicine, University of Toronto, Ontario, Canada.

The American Journal of Medicine
|October 21, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An unusual case of alpha-1-antitrypsin deficiency: SZ/Z.

Clinical biochemistry·2018
Same author

Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study.

Thorax·2015
Same author

Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study.

Thorax·2014
Same author

Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.

Canadian respiratory journal·2012
Same author

The clinical impact of single inhaler therapy in asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2012
Same author

A 21-year-old man with systemic-onset juvenile rheumatoid arthritis, cough and progressive dyspnea.

Canadian respiratory journal·2010
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric Panniculitis.

The American journal of medicine·2026
Same journal

Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

The American journal of medicine·2026
See all related articles

Managing chronic obstructive pulmonary disease (COPD) requires individualized plans due to its complexity. Key steps include smoking cessation, vaccinations, and targeted bronchodilator therapy, with further options for persistent symptoms.

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Internal Medicine

Background:

  • Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with uncertain pathogenesis.
  • Standardized treatment protocols may not be suitable due to disease variability.

Purpose of the Study:

  • To outline principles for guiding individualized treatment plans for COPD management.
  • To emphasize a flexible, patient-centered approach rather than a rigid protocol.

Main Methods:

  • Review and synthesis of current understanding of COPD management principles.
  • Identification of key therapeutic interventions based on symptom presentation and disease severity.

Main Results:

  • Smoking cessation is crucial for slowing pulmonary function decline.

Related Experiment Videos

  • Inhaled anticholinergics are recommended as first-line bronchodilators.
  • Vaccinations, oral steroids, exercise rehabilitation, and oxygen therapy are important components for specific patient groups.

    • Conclusions:

    • Individualized management plans are essential for COPD.
    • A stepwise approach incorporating smoking cessation, pharmacotherapy, and supportive measures optimizes patient outcomes.
    • Further research is needed for investigational therapies like antioxidant administration and lung transplantation.